IBB
IBB
iShares Biotechnology ETF • IShares
$175.37 ▲ 0.86% (+1.49)
Managing Company IShares
Asset Under Management $8.78B
Inception Date Feb 5, 2001
Expense Ratio 0.44%
52w High $179.64
52w Low $107.43
Volume 653,593
Avg Volume 1,767,049
Asset Class Equity
About iShares Biotechnology ETF
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
Managing Company IShares
Asset Under Management $8.78B
Inception Date Feb 5, 2001
Expense Ratio 0.44%
52w High $179.64
52w Low $107.43
Volume 653,593
Avg Volume 1,767,049
Asset Class Equity
About iShares Biotechnology ETF
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 GILD | Gilead Sciences, Inc. | 9.16% | 5.55M | $798.26M |
 VRTX | Vertex Pharmaceuticals Incorporated | 8.88% | 1.61M | $773.67M |
 AMGN | Amgen Inc. | 8.81% | 2.02M | $767.20M |
 REGN | Regeneron Pharmaceuticals, Inc. | 6.68% | 755.18K | $582.08M |
 ALNY | Alnylam Pharmaceuticals, Inc. | 3.68% | 968.40K | $320.77M |
 INSM | Insmed Incorporated | 2.70% | 1.57M | $235.43M |
 ARGX | argenx SE | 2.68% | 302.05K | $233.04M |
 NTRA | Natera, Inc. | 2.43% | 980.18K | $211.82M |
 BIIB | Biogen Inc. | 2.36% | 1.09M | $205.50M |
 ONC | BeOne Medicines Ltd. | 2.00% | 539.62K | $173.96M |
 UTHR | United Therapeutics Corporation | 1.79% | 309.98K | $156.11M |
 INCY | Incyte Corporation | 1.67% | 1.45M | $145.05M |
 ILMN | Illumina, Inc. | 1.62% | 1.11M | $141.21M |
 MRNA | Moderna, Inc. | 1.54% | 2.59M | $133.75M |
 RVMD | Revolution Medicines, Inc. | 1.45% | 1.23M | $126.02M |
 GMAB | Genmab A/S | 1.23% | 3.67M | $107.30M |
 IONS | Ionis Pharmaceuticals, Inc. | 1.10% | 1.19M | $95.55M |
 NBIX | Neurocrine Biosciences, Inc. | 1.09% | 724.48K | $94.65M |
 ROIV | Roivant Sciences Ltd. | 1.06% | 3.23M | $92.02M |
 BMRN | BioMarin Pharmaceutical Inc. | 0.99% | 1.41M | $86.33M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Netherlands
Denmark
United Kingdom
Germany
Canada
France
Ireland
Switzerland Other
0.25%
Singapore
China
Australia
Belgium
Spain
Jersey
Cayman Islands
Italy
Iceland.svg)
Taiwan (Province of China)SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Netherlands Denmark United Kingdom Germany Canada France Ireland Switzerland Other
0.25% Singapore China Australia Belgium Spain Jersey Cayman Islands Italy Iceland Taiwan (Province of China)Holdings (Top 20)
GILD
Gilead Sciences, Inc.
Weight: 9.16% Shares: 5.55M Value: $798.26M
VRTX
Vertex Pharmaceuticals Incorporated
Weight: 8.88% Shares: 1.61M Value: $773.67M
AMGN
Amgen Inc.
Weight: 8.81% Shares: 2.02M Value: $767.20M
REGN
Regeneron Pharmaceuticals, Inc.
Weight: 6.68% Shares: 755.18K Value: $582.08M
ALNY
Alnylam Pharmaceuticals, Inc.
Weight: 3.68% Shares: 968.40K Value: $320.77M
INSM
Insmed Incorporated
Weight: 2.70% Shares: 1.57M Value: $235.43M
ARGX
argenx SE
Weight: 2.68% Shares: 302.05K Value: $233.04M
NTRA
Natera, Inc.
Weight: 2.43% Shares: 980.18K Value: $211.82M
BIIB
Biogen Inc.
Weight: 2.36% Shares: 1.09M Value: $205.50M
ONC
BeOne Medicines Ltd.
Weight: 2.00% Shares: 539.62K Value: $173.96M
UTHR
United Therapeutics Corporation
Weight: 1.79% Shares: 309.98K Value: $156.11M
INCY
Incyte Corporation
Weight: 1.67% Shares: 1.45M Value: $145.05M
ILMN
Illumina, Inc.
Weight: 1.62% Shares: 1.11M Value: $141.21M
MRNA
Moderna, Inc.
Weight: 1.54% Shares: 2.59M Value: $133.75M
RVMD
Revolution Medicines, Inc.
Weight: 1.45% Shares: 1.23M Value: $126.02M
GMAB
Genmab A/S
Weight: 1.23% Shares: 3.67M Value: $107.30M
IONS
Ionis Pharmaceuticals, Inc.
Weight: 1.10% Shares: 1.19M Value: $95.55M
NBIX
Neurocrine Biosciences, Inc.
Weight: 1.09% Shares: 724.48K Value: $94.65M
ROIV
Roivant Sciences Ltd.
Weight: 1.06% Shares: 3.23M Value: $92.02M
BMRN
BioMarin Pharmaceutical Inc.
Weight: 0.99% Shares: 1.41M Value: $86.33M